Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

236 ARTÍCULOS , VIENDO DEL 121 AL 135

Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer's Disease

Castaneda A, Ferraz R, Vieira M, Cardoso I, Vasconcelos V, Martins R.

Mar Drugs. 2021 Jun 16;19(6):343. doi: 10.3390/md19060343.

Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants

Squitti R, Ventriglia M, Simonelli I, Bonvicini C, Costa A, Perini G, Binetti G, Benussi L, Ghidoni R, Koch G, Borroni B, Albanese A, Sensi SL, Rongioletti M.

Biomolecules. 2021 Jun 29;11(7):960. doi: 10.3390/biom11070960.

The next step of neurogenesis in the context of Alzheimer's disease

Moradi HR, Hajali V, Khaksar Z, Vafaee F, Forouzanfar F, Negah SS.

Mol Biol Rep. 2021 Jul;48(7):5647-5660. doi: 10.1007/s11033-021-06520-9. Epub 2021 Jul 7.

The blood biomarkers puzzle - A review of protein biomarkers in neurodegenerative diseases

Barro C, Zetterberg H.

J Neurosci Methods. 2021 Sep 1;361:109281. doi: 10.1016/j.jneumeth.2021.109281. Epub 2021 Jul 6.

Developing the ATX(N) classification for use across the Alzheimer disease continuum

Hampel H, Cummings J, Blennow K, Gao P, Jack CR Jr, Vergallo A.

Nat Rev Neurol. 2021 Sep;17(9):580-589. doi: 10.1038/s41582-021-00520-w. Epub 2021 Jul 8.

Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning

Yuen SC, Liang X, Zhu H, Jia Y, Leung SW.

Alzheimers Res Ther. 2021 Jul 9;13(1):126. doi: 10.1186/s13195-021-00862-z.

Mass spectrometry-based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids

Korecka M, Shaw LM.

J Neurochem. 2021 Oct;159(2):211-233. doi: 10.1111/jnc.15465. Epub 2021 Aug 25.

Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis

Qu Y, Ma YH, Huang YY, Ou YN, Shen XN, Chen SD, Dong Q, Tan L, Yu JT.

Neurosci Biobehav Rev. 2021 Sep;128:479-486. doi: 10.1016/j.neubiorev.2021.07.007. Epub 2021 Jul 7.

The role of the immune system in Alzheimer's disease

Wu KM, Zhang YR, Huang YY, Dong Q, Tan L, Yu JT.

Ageing Res Rev. 2021 Sep;70:101409. doi: 10.1016/j.arr.2021.101409. Epub 2021 Jul 14.

Role of TREM2 in Alzheimer's Disease: A Long Road Ahead

Kulkarni B, Kumar D, Cruz-Martins N, Sellamuthu S.

Mol Neurobiol. 2021 Oct;58(10):5239-5252. doi: 10.1007/s12035-021-02477-9. Epub 2021 Jul 18.

The human connectome in Alzheimer disease - relationship to biomarkers and genetics

Yu M, Sporns O, Saykin AJ.

Nat Rev Neurol. 2021 Sep;17(9):545-563. doi: 10.1038/s41582-021-00529-1. Epub 2021 Jul 20.

Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study

Libowitz MR, Wei K, Tran T, Chu K, Moncrieffe K, Harrington MG, King K.

PLoS One. 2021 Jul 22;16(7):e0254332. doi: 10.1371/journal.pone.0254332. eCollection 2021.

Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease

Kim N, Lee HJ.

Int J Mol Sci. 2021 Jul 19;22(14):7697. doi: 10.3390/ijms22147697.

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, Goate A, Ances BM, Doran E, Christian BT, Lai F, Rosas HD, Schupf N, Krinsky-McHale S, Silverman W, Lee JH, Klunk WE, Handen BL, Allegri RF, Chhatwal JP, Day GS, Graff-Radford NR, Jucker M, Levin J, Martins RN, Masters CL, Mori H, Mummery CJ, Niimi Y, Ringman JM, Salloway S, Schofield PR, Shoji M, Lott IT; Alzheimer's Biomarker Consortium–Down Syndrome; Dominantly Inherited Alzheimer Network.

Lancet Neurol. 2021 Aug;20(8):615-626. doi: 10.1016/S1474-4422(21)00139-3.

Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype

Motta C, Assogna M, Bonomi CG, Mascolo AP, De Lucia V, Semprini R, Mercuri NB, Koch G, Martorana A.

Eur J Neurol. 2021 Dec;28(12):3965-3971. doi: 10.1111/ene.15039. Epub 2021 Aug 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias